|
1
|
Tzouvelekis LS, Markogiannakis A,
Psichogiou M, Tassios PT and Daikos GL: Carbapenemases in
Klebsiella pneumoniae and other Enterobacteriaceae: An evolving
crisis of global dimensions. Clin Microbiol Rev. 25:682–707. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Daikos GL, Tsaousi S, Tzouvelekis LS,
Anyfantis I, Psichogiou M, Argyropoulou A, Stefanou I, Sypsa V,
Miriagou V, Nepka M, et al: Carbapenemase-producing Klebsiella
pneumoniae bloodstream infections: Lowering mortality by antibiotic
combination schemes and the role of carbapenems. Antimicrob Agents
Chemother. 58:2322–2328. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Fraenkel-Wandel Y, Raveh-Brawer D,
Wiener-Well Y, Yinnon AM and Assous MV: Mortality due to blaKPC
Klebsiella peumoniae bacteraemia. J Antimicrob Chemother.
71:1083–1087. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Qureshi ZA, Paterson DL, Potoski BA,
Kilayko MC, Sandovsky G, Sordillo E, Polsky B, Adams-Haduch JM and
Doi Y: Treatment outcome of bacteremia due to KPC-producing
Klebsiella pneumoniae: Superiority of combination antimicrobial
regimens. Antimicrob Agents Chemother. 56:2108–2113. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Falagas ME, Rafailidis PI, Kofteridis D,
Virtzili S, Chelvatzoglou FC, Papaioannou V, Maraki S, Samonis G
and Michalopoulos A: Risk factors of carbapenem-resistant
Klebsiella pneumoniae infections: A matched case control study. J
Antimicrob Chemother. 60:1124–1130. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Schwaber MJ, Klarfeld-Lidji S,
Navon-Venezia S, Schwartz D, Leavitt A and Carmeli Y: Predictors of
carbapenem-resistant Klebsiella pneumoniae acquisition among
hospitalized adults and effect of acquisition on mortality.
Antimicrob Agents Chemother. 52:1028–1033. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tumbarello M, Trecarichi EM, Tumietto F,
Del Bono V, De Rosa FG, Bassetti M, Losito AR, Tedeschi S, Saffioti
C, Corcione S, et al: Predictive models for identification of
hospitalized patients harboring KPC-producing Klebsiella
pneumoniae. Antimicrob Agents Chemother. 58:3514–3520. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zarkotou O, Pournaras S, Voulgari E,
Chrysos G, Prekates A, Voutsinas D, Themeli-Digalaki K and Tsakris
A: Risk factors and outcomes associated with acquisition of
colistin-resistant KPC-producing Klebsiella pneumoniae: A matched
case-control study. J Clin Microbiol. 48:2271–2274. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Horan TC, Andrus M and Dudeck MA: CDC/NHSN
surveillance definition of health care-associated infection and
criteria for specific types of infections in the acute care
setting. Am J Infect Control. 36:309–332. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Clinical and Laboratory Standards
Institute (CLSI). Methods for dilution antimicrobial susceptibility
tests for bacteria that grow aerobically; Approved standard
M100CLSI; Wayne, PA: 2012
|
|
11
|
Rodríguez-Baño J, Alcalá JC, Cisneros JM,
Grill F, Oliver A, Horcajada JP, Tórtola T, Mirelis B, Navarro G,
Cuenca M, et al: Community infections caused by extended-spectrum
beta-lactamase-producing Escherichia coli. Arch Intern Med.
168:1897–1902. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Pilote L, Dasgupta K, Guru V, Humphries
KH, McGrath J, Norris C, Rabi D, Tremblay J, Alamian A, Barnett T,
et al: A comprehensive view of sex-specific issues related to
cardiovascular disease. CMAJ. 176:S1–S44. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Trecarichi EM, Cauda R and Tumbarello M:
Detecting risk and predicting patient mortality in patients with
extended-spectrum β-lactamase-producing Enterobacteriaceae
bloodstream infections. Future Microbiol. 7:1173–1189. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lucena A, Dalla Costa LM, Nogueira KS,
Matos AP, Gales AC, Paganini MC, Castro ME and Raboni SM:
Nosocomial infections with metallo-beta-lactamase-producing
Pseudomonas aeruginosa: Molecular epidemiology, risk factors,
clinical features and outcomes. J Hosp Infect. 87:234–240. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lin MY, Lyles-Banks RD, Lolans K, Hines
DW, Spear JB, Petrak R, Trick WE, Weinstein RA and Hayden MK:
Centers for Disease Control and Prevention Epicenters Program: The
importance of long-term acute care hospitals in the regional
epidemiology of Klebsiella pneumoniae carbapenemase-producing
Enterobacteriaceae. Clin Infect Dis. 57:1246–1252. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Papadimitriou-Olivgeris M, Marangos M,
Fligou F, Christofidou M, Bartzavali C, Anastassiou ED and Filos
KS: Risk factors for KPC-producing Klebsiella pneumoniae enteric
colonization upon ICU admission. J Antimicrob Chemother.
67:2976–2981. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Papadimitriou-Olivgeris M, Christofidou M,
Fligou F, Bartzavali C, Vrettos T, Filos KS, Marangos M and
Anastassiou ED: The role of colonization pressure in the
dissemination of colistin or tigecycline resistant KPC-producing
Klebsiella pneumoniae in critically ill patients. Infection.
42:883–890. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Bonten MJ: Colonization pressure: A
critical parameter in the epidemiology of antibiotic-resistant
bacteria. Crit Care. 16:1422012.PubMed/NCBI
|
